(Q38818013)

English

AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma

scientific article published on 20 November 2015

Statements

AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma (English)
Fernando Doñate
Kendall Morrison
Daulet Satpayev
Ingrid B J Joseph
Daniel S Pereira
Pia M Challita-Eid

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit